Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
JOURNAL ARTICLE
David Haosen Xiang
No abstract text is available yet for this article.
September 7, 2023: JAMA Oncology
#22
JOURNAL ARTICLE
Thomas J Hwang, Benjamin J Davies, Mark A Preston
No abstract text is available yet for this article.
September 7, 2023: JAMA Oncology
#23
JOURNAL ARTICLE
Amanda Ramos da Cunha, Kelly Compton, Rixing Xu, Rashmi Mishra, Mark Thomas Drangsholt, Jose Leopoldo Ferreira Antunes, Alexander R Kerr, Alistair R Acheson, Dan Lu, Lindsey E Wallace, Jonathan M Kocarnik, Weijia Fu, Frances E Dean, Alyssa Pennini, Hannah Jacqueline Henrikson, Tahiya Alam, Emad Ababneh, Sherief Abd-Elsalam, Meriem Abdoun, Hassan Abidi, Hiwa Abubaker Ali, Eman Abu-Gharbieh, Tigist Demssew Adane, Isaac Yeboah Addo, Aqeel Ahmad, Sajjad Ahmad, Tarik Ahmed Rashid, Maxwell Akonde, Hanadi Al Hamad, Fares Alahdab, Yousef Alimohamadi, Vahid Alipour, Sadeq Ali Al-Maweri, Ubai Alsharif, Alireza Ansari-Moghaddam, Sumadi Lukman Anwar, Anayochukwu Edward Anyasodor, Jalal Arabloo, Aleksandr Y Aravkin, Raphael Taiwo Aruleba, Malke Asaad, Tahira Ashraf, Seyyed Shamsadin Athari, Sameh Attia, Sina Azadnajafabad, Mohammadreza Azangou-Khyavy, Muhammad Badar, Nayereh Baghcheghi, Maciej Banach, Mainak Bardhan, Hiba Jawdat Barqawi, Nasir Z Bashir, Azadeh Bashiri, Habib Benzian, Eduardo Bernabe, Devidas S Bhagat, Vijayalakshmi S Bhojaraja, Tone Bjørge, Souad Bouaoud, Dejana Braithwaite, Nikolay Ivanovich Briko, Daniela Calina, Giulia Carreras, Promit Ananyo Chakraborty, Vijay Kumar Chattu, Akhilanand Chaurasia, Meng Xuan Chen, William C S Cho, Dinh-Toi Chu, Isaac Sunday Chukwu, Eunice Chung, Natália Cruz-Martins, Omid Dadras, Xiaochen Dai, Lalit Dandona, Rakhi Dandona, Parnaz Daneshpajouhnejad, Reza Darvishi Cheshmeh Soltani, Aso Mohammad Darwesh, Sisay Abebe Debela, Meseret Derbew Molla, Fikadu Nugusu Dessalegn, Mostafa Dianati-Nasab, Lankamo Ena Digesa, Shilpi Gupta Dixit, Abhinav Dixit, Shirin Djalalinia, Iman El Sayed, Maha El Tantawi, Daniel Berhanie Enyew, Daniel Asfaw Erku, Rana Ezzeddini, Adeniyi Francis Fagbamigbe, Luca Falzone, Getahun Fetensa, Takeshi Fukumoto, Piyada Gaewkhiew, Silvano Gallus, Mesfin Gebrehiwot, Ahmad Ghashghaee, Paramjit Singh Gill, Mahaveer Golechha, Pouya Goleij, Ricardo Santiago Gomez, Giuseppe Gorini, Andre Luiz Sena Guimaraes, Bhawna Gupta, Sapna Gupta, Veer Bala Gupta, Vivek Kumar Gupta, Arvin Haj-Mirzaian, Esam S Halboub, Rabih Halwani, Asif Hanif, Ninuk Hariyani, Mehdi Harorani, Hamidreza Hasani, Abbas M Hassan, Soheil Hassanipour, Mohammed Bheser Hassen, Simon I Hay, Khezar Hayat, Brenda Yuliana Herrera-Serna, Ramesh Holla, Nobuyuki Horita, Mehdi Hosseinzadeh, Salman Hussain, Olayinka Stephen Ilesanmi, Irena M Ilic, Milena D Ilic, Gaetano Isola, Abhishek Jaiswal, Chinmay T Jani, Tahereh Javaheri, Umesh Jayarajah, Shubha Jayaram, Nitin Joseph, Vidya Kadashetti, Eswar Kandaswamy, Shama D Karanth, Ibraheem M Karaye, Joonas H Kauppila, Harkiran Kaur, Mohammad Keykhaei, Yousef Saleh Khader, Himanshu Khajuria, Javad Khanali, Mahalaqua Nazli Khatib, Hamid Reza Khayat Kashani, Mohammad Amin Khazeei Tabari, Min Seo Kim, Farzad Kompani, Hamid Reza Koohestani, G Anil Kumar, Om P Kurmi, Carlo La Vecchia, Dharmesh Kumar Lal, Iván Landires, Savita Lasrado, Caterina Ledda, Yo Han Lee, Massimo Libra, Stephen S Lim, Stefan Listl, Platon D Lopukhov, Ahmad R Mafi, Rashidul Alam Mahumud, Ahmad Azam Malik, Manu Raj Mathur, Sazan Qadir Maulud, Jitendra Kumar Meena, Entezar Mehrabi Nasab, Tomislav Mestrovic, Reza Mirfakhraie, Awoke Misganaw, Sanjeev Misra, Prasanna Mithra, Yousef Mohammad, Mokhtar Mohammadi, Esmaeil Mohammadi, Ali H Mokdad, Mohammad Ali Moni, Paula Moraga, Shane Douglas Morrison, Hamid Reza Mozaffari, Sumaira Mubarik, Christopher J L Murray, Tapas Sadasivan Nair, Sreenivas Narasimha Swamy, Aparna Ichalangod Narayana, Hasan Nassereldine, Zuhair S Natto, Biswa Prakash Nayak, Serban Mircea Negru, Haruna Asura Nggada, Hasti Nouraei, Virginia Nuñez-Samudio, Bogdan Oancea, Andrew T Olagunju, Ahmed Omar Bali, Alicia Padron-Monedero, Jagadish Rao Padubidri, Anamika Pandey, Shahina Pardhan, Jay Patel, Raffaele Pezzani, Zahra Zahid Piracha, Navid Rabiee, Venkatraman Radhakrishnan, Raghu Anekal Radhakrishnan, Amir Masoud Rahmani, Vahid Rahmanian, Chythra R Rao, Sowmya J Rao, Goura Kishor Rath, David Laith Rawaf, Salman Rawaf, Reza Rawassizadeh, Mohammad Sadegh Razeghinia, Nazila Rezaei, Negar Rezaei, Nima Rezaei, Aziz Rezapour, Abanoub Riad, Thomas J Roberts, Esperanza Romero-Rodríguez, Gholamreza Roshandel, Manjula S, Chandan S N, Basema Saddik, Mohammad Reza Saeb, Umar Saeed, Mohsen Safaei, Maryam Sahebazzamani, Amirhossein Sahebkar, Amir Salek Farrokhi, Abdallah M Samy, Milena M Santric-Milicevic, Brijesh Sathian, Maheswar Satpathy, Mario Šekerija, Subramanian Senthilkumaran, Allen Seylani, Omid Shafaat, Hamid R Shahsavari, Erfan Shamsoddin, Mequannent Melaku Sharew, Javad Sharifi-Rad, Jeevan K Shetty, K M Shivakumar, Parnian Shobeiri, Seyed Afshin Shorofi, Sunil Shrestha, Sudeep K Siddappa Malleshappa, Paramdeep Singh, Jasvinder A Singh, Garima Singh, Dhirendra Narain Sinha, Yonatan Solomon, Muhammad Suleman, Rizwan Suliankatchi Abdulkader, Yasaman Taheri Abkenar, Iman M Talaat, Ker-Kan Tan, Abdelghani Tbakhi, Arulmani Thiyagarajan, Amir Tiyuri, Marcos Roberto Tovani-Palone, Bhaskaran Unnikrishnan, Bay Vo, Simona Ruxandra Volovat, Cong Wang, Ronny Westerman, Nuwan Darshana Wickramasinghe, Hong Xiao, Chuanhua Yu, Deniz Yuce, Ismaeel Yunusa, Vesna Zadnik, Iman Zare, Zhi-Jiang Zhang, Mohammad Zoladl, Lisa M Force, Fernando N Hugo
IMPORTANCE: Lip, oral, and pharyngeal cancers are important contributors to cancer burden worldwide, and a comprehensive evaluation of their burden globally, regionally, and nationally is crucial for effective policy planning. OBJECTIVE: To analyze the total and risk-attributable burden of lip and oral cavity cancer (LOC) and other pharyngeal cancer (OPC) for 204 countries and territories and by Socio-demographic Index (SDI) using 2019 Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study estimates...
September 7, 2023: JAMA Oncology
#24
JOURNAL ARTICLE
Gaia Giannone, Iain A McNeish, Susana Banerjee
No abstract text is available yet for this article.
September 7, 2023: JAMA Oncology
#25
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
August 31, 2023: JAMA Oncology
#26
JOURNAL ARTICLE
Abdulhadi Jfri, Lauren Guggina
No abstract text is available yet for this article.
August 31, 2023: JAMA Oncology
#27
JOURNAL ARTICLE
Alexandra L Potter, Chi-Fu Jeffrey Yang, Julie R Palmer
No abstract text is available yet for this article.
August 31, 2023: JAMA Oncology
#28
JOURNAL ARTICLE
Austin Wesevich, Mark J Ratain
No abstract text is available yet for this article.
August 31, 2023: JAMA Oncology
#29
JOURNAL ARTICLE
Anthony V Serritella, Niraj K Shenoy
IMPORTANCE: Although the combination of nivolumab plus ipilimumab has unquestionable benefit over nivolumab monotherapy in advanced melanoma, currently no summative analyses have compared the combination with nivolumab monotherapy for advanced cancers other than melanoma. OBJECTIVE: To examine whether the addition of ipilimumab to standard-dose nivolumab safely improves clinical outcomes in patients with advanced cancers other than melanoma. DATA SOURCES: Electronic databases (PubMed, EBSCO Information Services, Embase, and Cochrane Library) were systematically searched for studies of standard-dose nivolumab plus ipilimumab vs nivolumab alone in the treatment of advanced cancers other than melanoma published from database inception to October 31, 2022...
August 31, 2023: JAMA Oncology
#30
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
August 31, 2023: JAMA Oncology
#31
JOURNAL ARTICLE
Dan-Na Wu, Guo Yu, Guo-Fu Li
No abstract text is available yet for this article.
August 31, 2023: JAMA Oncology
#32
JOURNAL ARTICLE
Alexandra L Potter, Vedha Vaddaraju, Shivaek Venkateswaran, Arian Mansur, Simar S Bajaj, Mathew V Kiang, Anupam B Jena, Chi-Fu Jeffrey Yang
IMPORTANCE: With the ongoing relaxation of guidelines to prevent COVID-19 transmission, particularly in hospital settings, medically vulnerable groups, such as patients with cancer, may experience a disparate burden of COVID-19 mortality compared with the general population. OBJECTIVE: To evaluate COVID-19 mortality among US patients with cancer compared with the general US population during different waves of the pandemic. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the Center for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research database to examine COVID-19 mortality among US patients with cancer and the general population from March 1, 2020, to May 31, 2022...
August 31, 2023: JAMA Oncology
#33
JOURNAL ARTICLE
Shan Chen, Benjamin H Kann, Michael B Foote, Hugo J W L Aerts, Guergana K Savova, Raymond H Mak, Danielle S Bitterman
No abstract text is available yet for this article.
August 24, 2023: JAMA Oncology
#34
JOURNAL ARTICLE
Jonathan Strosberg, Taymeyah Al-Toubah, Mauro Cives
No abstract text is available yet for this article.
August 24, 2023: JAMA Oncology
#35
JOURNAL ARTICLE
Donald R Sullivan, William E Rosa, Abby R Rosenberg
No abstract text is available yet for this article.
August 24, 2023: JAMA Oncology
#36
JOURNAL ARTICLE
Alexander Pan, David Musheyev, Daniel Bockelman, Stacy Loeb, Abdo E Kabarriti
IMPORTANCE: Consumers are increasingly using artificial intelligence (AI) chatbots as a source of information. However, the quality of the cancer information generated by these chatbots has not yet been evaluated using validated instruments. OBJECTIVE: To characterize the quality of information and presence of misinformation about skin, lung, breast, colorectal, and prostate cancers generated by 4 AI chatbots. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study assessed AI chatbots' text responses to the 5 most commonly searched queries related to the 5 most common cancers using validated instruments...
August 24, 2023: JAMA Oncology
#37
JOURNAL ARTICLE
Brian W Labadie, Antonio Tito Fojo
No abstract text is available yet for this article.
August 24, 2023: JAMA Oncology
#38
JOURNAL ARTICLE
Enrui Xie, Yee Hui Yeo, Bernhard Scheiner, Yue Zhang, Atsushi Hiraoka, Xinxing Tantai, Petros Fessas, Tiago de Castro, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Shuo Xu, Hong-Ming Tsai, Swetha Kambhampati, Wenjun Wang, Bridget P Keenan, Xu Gao, Zixuan Xing, Matthias Pinter, Yih-Jyh Lin, Zhanjun Guo, Arndt Vogel, Takaaki Tanaka, Hsin-Yu Kuo, Robin K Kelley, Masatoshi Kudo, Ju Dong Yang, David J Pinato, Fanpu Ji
IMPORTANCE: Immune checkpoint inhibitors (ICIs) are increasingly used in patients with advanced hepatocellular carcinoma (HCC). However, data on ICI therapy in patients with advanced HCC and impaired liver function are scarce. OBJECTIVE: To conduct a systematic review and meta-analysis to determine the efficacy and safety of ICI treatment for advanced HCC with Child-Pugh B liver function. DATA SOURCES: PubMed, Embase, Web of Science, and Cochrane Library were searched for relevant studies from inception through June 15, 2022...
August 24, 2023: JAMA Oncology
#39
JOURNAL ARTICLE
Atul J Butte
No abstract text is available yet for this article.
August 24, 2023: JAMA Oncology
#40
JOURNAL ARTICLE
Alison Galbraith, Annette Flanagin, Aaron E Carroll, John Z Ayanian, Robert O Bonow, Neil Bressler, Dimitri Christakis, Mary L Nora Disis, Sharon K Inouye, Andrew Josephson, Dost Öngür, Jay F Piccirillo, Kanade Shinkai, Kirsten Bibbins-Domingo
No abstract text is available yet for this article.
August 18, 2023: JAMA Oncology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
